Hepatitis a: changes in the epidemiological pattern
Main Author: | |
---|---|
Publication Date: | 2000 |
Other Authors: | , , |
Format: | Article |
Language: | por |
Source: | Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
Download full: | https://doi.org/10.32385/rpmgf.v16i2.9786 |
Summary: | Introduction: There is evidence, that is corroborated by several other authors, pointing toward a change in the epidemiological patterns of hepatitis A in various European, American, and even Asian countries. Knowing the current prevalence of anti-hepatitis A virus (anti-HAV) antibodies is thus imperative, all the more so that the anti-hepatitis A vaccine has begun to be marketed in Portugal. Objective: To assess the current prevalence of anti-HAV antibodies in an urban population of health professionals and medical students from the Santa Maria Hospital in Lisbon. Population: 526 subjects were studied, of which 325 were health professionals from diverse age and professional groups from the Santa Maria Hospital, and 201 were students from various pre-graduate years of the Medical School. Methods: Total anti-HAV antibodies were determined by an immune-enzymatic assay using a commercial kit. Results: The global prevalence of anti-HAV antibodies was 86.4% in health professionals, and 35.3% in students, this difference being statistically significant (p |
id |
RCAP_8a6010b2c53ae9f6f4a92ac9d6c2f51e |
---|---|
oai_identifier_str |
oai:ojs.rpmgf.pt:article/9786 |
network_acronym_str |
RCAP |
network_name_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository_id_str |
https://opendoar.ac.uk/repository/7160 |
spelling |
Hepatitis a: changes in the epidemiological patternHepatite a: alteração do padrão epidemiológicoHepatite AVacinaEpidemiologiaHepatitis AVaccineEpidemiologyIntroduction: There is evidence, that is corroborated by several other authors, pointing toward a change in the epidemiological patterns of hepatitis A in various European, American, and even Asian countries. Knowing the current prevalence of anti-hepatitis A virus (anti-HAV) antibodies is thus imperative, all the more so that the anti-hepatitis A vaccine has begun to be marketed in Portugal. Objective: To assess the current prevalence of anti-HAV antibodies in an urban population of health professionals and medical students from the Santa Maria Hospital in Lisbon. Population: 526 subjects were studied, of which 325 were health professionals from diverse age and professional groups from the Santa Maria Hospital, and 201 were students from various pre-graduate years of the Medical School. Methods: Total anti-HAV antibodies were determined by an immune-enzymatic assay using a commercial kit. Results: The global prevalence of anti-HAV antibodies was 86.4% in health professionals, and 35.3% in students, this difference being statistically significant (pIntrodução: Existe uma evidência, corroborada por diversos autores, no sentido da alteração dos padrões epidemiológicos da Hepatite A em diversos países não só europeus como também do continente americano e até asiático. O conhecimento da prevalência actual dos anticorpos contra o vírus da hepatite A (anti-VHA), torna-se pois imperativo, reforçado pelo início da comercialização da vacina anti-hepatite A. Objectivo: O objectivo deste estudo consistiu em avaliar a prevalência actual do anticorpo anti-VHA numa população de características urbanas, trabalhadores de saúde e estudantes de Medicina do Hospital Santa Maria em Lisboa. População: Foram estudados 526 indivíduos, 325 profissionais de saúde pertencentes a diversos escalões etários e diferentes grupos profissionais do Hospital e 201 alunos dos diversos anos da Faculdade de Medicina. Métodos: Determinação do anti-VHA total por método imunoenzimático através de Kit comercial. Resultados: A prevalência do anti-VHA global foi de 86,4% nos profissionais de saúde e de 35,3% nos alunos, sendo esta diferença estatísticamente significativa, pAssociação Portuguesa de Medicina Geral e Familiar2000-03-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.32385/rpmgf.v16i2.9786https://doi.org/10.32385/rpmgf.v16i2.9786Portuguese Journal of Family Medicine and General Practice; Vol. 16 No. 2 (2000): Revista Portuguesa de Clínica Geral; 103-11Revista Portuguesa de Medicina Geral e Familiar; Vol. 16 Núm. 2 (2000): Revista Portuguesa de Clínica Geral; 103-11Revista Portuguesa de Medicina Geral e Familiar; Vol. 16 N.º 2 (2000): Revista Portuguesa de Clínica Geral; 103-112182-51812182-517310.32385/rpmgf.v16i2reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAPporhttps://rpmgf.pt/ojs/index.php/rpmgf/article/view/9786https://rpmgf.pt/ojs/index.php/rpmgf/article/view/9786/9524Marinho, Rui TatoValente, AnaRamalho, FernandoMoura., M. Carneiro Deinfo:eu-repo/semantics/openAccess2024-09-17T11:58:08Zoai:ojs.rpmgf.pt:article/9786Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T18:50:26.091313Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse |
dc.title.none.fl_str_mv |
Hepatitis a: changes in the epidemiological pattern Hepatite a: alteração do padrão epidemiológico |
title |
Hepatitis a: changes in the epidemiological pattern |
spellingShingle |
Hepatitis a: changes in the epidemiological pattern Marinho, Rui Tato Hepatite A Vacina Epidemiologia Hepatitis A Vaccine Epidemiology |
title_short |
Hepatitis a: changes in the epidemiological pattern |
title_full |
Hepatitis a: changes in the epidemiological pattern |
title_fullStr |
Hepatitis a: changes in the epidemiological pattern |
title_full_unstemmed |
Hepatitis a: changes in the epidemiological pattern |
title_sort |
Hepatitis a: changes in the epidemiological pattern |
author |
Marinho, Rui Tato |
author_facet |
Marinho, Rui Tato Valente, Ana Ramalho, Fernando Moura., M. Carneiro De |
author_role |
author |
author2 |
Valente, Ana Ramalho, Fernando Moura., M. Carneiro De |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Marinho, Rui Tato Valente, Ana Ramalho, Fernando Moura., M. Carneiro De |
dc.subject.por.fl_str_mv |
Hepatite A Vacina Epidemiologia Hepatitis A Vaccine Epidemiology |
topic |
Hepatite A Vacina Epidemiologia Hepatitis A Vaccine Epidemiology |
description |
Introduction: There is evidence, that is corroborated by several other authors, pointing toward a change in the epidemiological patterns of hepatitis A in various European, American, and even Asian countries. Knowing the current prevalence of anti-hepatitis A virus (anti-HAV) antibodies is thus imperative, all the more so that the anti-hepatitis A vaccine has begun to be marketed in Portugal. Objective: To assess the current prevalence of anti-HAV antibodies in an urban population of health professionals and medical students from the Santa Maria Hospital in Lisbon. Population: 526 subjects were studied, of which 325 were health professionals from diverse age and professional groups from the Santa Maria Hospital, and 201 were students from various pre-graduate years of the Medical School. Methods: Total anti-HAV antibodies were determined by an immune-enzymatic assay using a commercial kit. Results: The global prevalence of anti-HAV antibodies was 86.4% in health professionals, and 35.3% in students, this difference being statistically significant (p |
publishDate |
2000 |
dc.date.none.fl_str_mv |
2000-03-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.32385/rpmgf.v16i2.9786 https://doi.org/10.32385/rpmgf.v16i2.9786 |
url |
https://doi.org/10.32385/rpmgf.v16i2.9786 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rpmgf.pt/ojs/index.php/rpmgf/article/view/9786 https://rpmgf.pt/ojs/index.php/rpmgf/article/view/9786/9524 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Associação Portuguesa de Medicina Geral e Familiar |
publisher.none.fl_str_mv |
Associação Portuguesa de Medicina Geral e Familiar |
dc.source.none.fl_str_mv |
Portuguese Journal of Family Medicine and General Practice; Vol. 16 No. 2 (2000): Revista Portuguesa de Clínica Geral; 103-11 Revista Portuguesa de Medicina Geral e Familiar; Vol. 16 Núm. 2 (2000): Revista Portuguesa de Clínica Geral; 103-11 Revista Portuguesa de Medicina Geral e Familiar; Vol. 16 N.º 2 (2000): Revista Portuguesa de Clínica Geral; 103-11 2182-5181 2182-5173 10.32385/rpmgf.v16i2 reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia instacron:RCAAP |
instname_str |
FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
collection |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository.name.fl_str_mv |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
repository.mail.fl_str_mv |
info@rcaap.pt |
_version_ |
1833597697716649984 |